Skip to main content
Equibles

ACORN CAPITAL ADVISORS, LLC

Position in KPTI — Karyopharm Therapeutics Inc.

CIK 2054410 NEW YORK, NY
Back to KPTI Full portfolio

Position in KPTI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$14,831,964
+$13,228,774 QoQ
Shares Held
1,518,113
+427.4% QoQ
Ownership
6.69%
of shares outstanding
% of Portfolio
4.05%
of 13F equity value
Holder Rank
#3
of 96 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KPTI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ACORN CAPITAL ADVISORS, LLC holds $366,458,500 across 20 Biotechnology names. KPTI ranks #8 (4.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CGON
CG Oncology, Inc.
 1,131,500 $80,393,075
2 URGN
UroGen Pharma Ltd.
 1,673,420 $61,581,856
3 TRVI
Trevi Therapeutics, Inc.
 2,144,844 $40,001,340
4 CADL
Candel Therapeutics, Inc.
 3,497,948 $36,028,864
5 PBYI
Puma Biotechnology, Inc.
 4,131,299 $33,504,834
6 JBIO
Jade Biosciences, Inc.
 986,760 $21,925,807
7 BCAX
Bicara Therapeutics Inc.
 643,381 $19,101,981
8 KPTI
Karyopharm Therapeutics Inc.
This page 		1,518,113 $14,831,964

All Filings in KPTI

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,831,964 1,518,113
2026-03-31 $1,603,190 287,826